Sarah B Kavanagh insider trades

Open-market stock purchases and sales by Sarah B Kavanagh, Director at Bausch & Lomb Corp, from SEC Form 4 filings since Jul 27, 2016.

Recent trades

DateStockTradeValue
May 26, 2026BLCO Bausch & Lomb CorpBought (not open market)$250K
May 22, 2026BHC Bausch Health Companies IncBought (not open market)—

Companies traded

  • BLCO Bausch & Lomb Corp: other filings, last May 26, 2026
  • BHC Bausch Health Companies Inc: other filings, last May 22, 2026
  • VRX Valeant Pharmaceuticals International, Inc: other filings, last May 3, 2018

Get free alerts when Sarah B Kavanagh files a new trade →